Thanks for the advice.
I’m happy with my understanding of biotech. There are many many many bio’s, with supposed high caliber management and boards who never succeed. And it’s not for the lack of knowledge.
Back to that patient. They had a stem cell transplant in addition to CHM treatment. I’ll put their response in the bin and focus on the other patients responses. Underwhelming, imv.
All the best.
- Forums
- ASX - By Stock
- CHM
- Ann: CORE NK Platform Phase 1 Clinical Data Presentation
CHM
chimeric therapeutics limited
Add to My Watchlist
25.0%
!
0.3¢

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
78 | 84735861 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 86304338 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 80251196 | 0.003 |
24 | 24996485 | 0.002 |
12 | 52464000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 86304338 | 23 |
0.005 | 33049651 | 21 |
0.006 | 12474007 | 15 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online